MiniHip™ combines the bone preserving benefits of hip resurfacing with the stability of traditional total hip replacement1.
It is designed for use as a primary cementless stem in active patients with good quality bone. Furthermore, the partial neck preservation design intent behind MiniHip allows for bone conservation and enables restoration of the biomechanics of multiple anatomies and the size and specific shape facilitates minimally invasive procedures2.
With over 10 years of implantations3 and MiniHip lives up to it’s 10A ODEP rating5
MiniHip heritage and continued success
Part of Corin’s Hip Continuum of care since 2008, MiniHip has yielded excellent clinical results and survivorship.
- Nearly 50,000 Implantations worldwide
- 98.66% survivorship for aseptic loosening at 10 yrs3
- Over 10 published clinical studies4
“Not just another short stem on the market - MiniHip is a conservative hip solution designed for restoring the biomechanics of active patients with good quality bone, resulting in reproducible implantations and results.”
Prof.Dr. med.Dr.h.c. Jörg Jerosch. Neuss, Germany.
What is ODEP?
ODEP (Orthopaedic Data Evaluation Panel) is an independent panel of experts comprised mainly of leading UK surgeons, but also non-clinical experts with deep experience of the orthopaedic industry. The Panel was set up by National Health Purchasing and Supply Agency (PASA, subsequently replaced by SCCL - the Supply Chain Coordination Limited NHS Supply Chain) as a response to National Institute for Health and Care Excellence (NICE) issuing guidance relating to Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hip (http://www.nice.org.uk/Guidance/TA304) - first publication April 2000, most recent publication in February 2014).
Implant manufacturers are invited to submit data regarding their orthopaedic implant products to ODEP. The panel reviews this submission and rates the strength of the evidence presented by the manufacturer, resulting in the award of an ODEP rating.
ODEP ratings explained
An ODEP rating should simply define a product’s clinical performance. It fundamentally consists of a NUMBER and a LETTER (and in some cases a STAR).
The number represents the number of years for which the product’s performance has been evidenced. Categories are 3, 5, 7, 10 and 13 years.
The letter represents the strength of evidence (data) presented by the manufacturer:
A* Very strong evidence.
A Strong evidence. Generally higher numbers of patients (giving greater confidence in the results presented), with all patients being subject to follow-up (their outcomes recorded).
B Acceptable evidence. Smaller numbers of patients giving less confidence in the results, but enough data to demonstrate compliance
There are ratings for new products that are registered with ODEP for which there is insufficient data to evidence the three-year entry benchmark but are currently undergoing clinical evaluation.
Pre-entry A* Products are being evaluated through the Beyond Compliance initiative, a post market surveillance service supported by ODEP.
Pre-entry Products not under Beyond Compliance, but which are registered with the National Joint Registry.
References:
- Lars V von Engelhardt, Andreas Breil-Wirth, Christian Kothny, Jörn Bengt Seeger, Christian Grasselli, Joerg Jerosch. Long-term results of an anatomically implanted hip arthroplasty with a short stem prosthesis (MiniHipTM). World Journal of Orthopedics, 2018 October 18; 9(10): 210-219.
- Khemka A, Mograby O, Lord S, Doyle Z, Bosley B, Al Muderis M. Total hip arthroplasty by the direct anterior approach using a neck preserving prosthesis – a learning curve. Poster at ICJR World Arthroplasty congress Paris April 2015
- Von Engelhardt LV, Breil-Wirth A, Kothny C, Seeger JB, Grasselli C, Jerosch J. Long-term results of an anatomically implanted hip arthroplasty with a short stem prosthesis (MiniHip™). World J Orthop. 2018 18;9(10):210-219.
- MiniHip Clinical evidence base document. Data on file
- Latest ODEP ratings can be found at www.odep.org.uk.
English
French